加载中…
Anti-FGFR3 Antibody (Vofatamab Biosimilar) is a research-use biosimilar antibody expressed in HEK293. The source page specifies target FGFR3, reactivity Human, isotype Human IgG1-Kappa, source-listed application ELISA.
FGFR3 is tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts.
